Real-time enrollment status for this ocular myasthenia gravis clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:45 PM UTC
| NCT Number | NCT07463521 |
| Recruiting Status | Recruiting |
| Condition | Ocular Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 120 participants |
| Active Locations | 5 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | October 9, 2026 (6 days ago) |
As of October 15, 2026: Clinical trial NCT07463521 is currently recruiting participants. This phase3 study for ocular myasthenia gravis is actively seeking new participants at 5 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07463521 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07463521 was last updated 6 days ago (October 9, 2026). HelloStudys verifies this status automatically.